Scarica l'app Stockscreener
1.54
1.28%
-0.02
Dopo l'orario di chiusura:
1.56
0.02
+1.30%
Precedente Chiudi:
$1.56
Aprire:
$1.56
Volume 24 ore:
388.97K
Relative Volume:
0.30
Capitalizzazione di mercato:
$275.27M
Reddito:
$156.37M
Utile/perdita netta:
$-37.49M
Rapporto P/E:
-7.3333
EPS:
-0.21
Flusso di cassa netto:
$-47.77M
1 W Prestazione:
+13.24%
1M Prestazione:
+6.94%
6M Prestazione:
-8.33%
1 anno Prestazione:
-10.47%
Intervallo 1D:
$1.50
$1.57
Intervallo di 1 settimana:
$1.33
$1.60
Portata 52W:
$1.12
$2.54
Cerus Corp Stock (CERS) Company Profile
Nome
Cerus Corp
Settore
Industria
Telefono
(925) 288-6000
Indirizzo
1220 CONCORD AVENUE, CONCORD, CA
Confronta CERS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.54 | 275.27M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-12 | Iniziato | Craig Hallum | Buy |
| 2023-01-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-17 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Iniziato | BTIG Research | Buy |
| 2019-11-13 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-08-28 | Iniziato | Stifel | Buy |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Ripresa | BTIG Research | Neutral |
| 2016-07-07 | Ripresa | Cantor Fitzgerald | Buy |
| 2015-12-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2014-05-02 | Reiterato | MLV & Co | Buy |
| 2013-04-24 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-15 | Reiterato | MLV & Co | Buy |
| 2012-04-17 | Iniziato | Cantor Fitzgerald | Buy |
| 2012-02-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Reiterato | MLV & Co | Buy |
| 2011-06-03 | Iniziato | Wedbush | Outperform |
| 2011-03-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Aggiornamento | Avondale | Mkt Perform → Mkt Outperform |
Mostra tutto
Cerus Corp Borsa (CERS) Ultime notizie
Daily Market Movement: Cerus Corp (CERS) Sees a 6.82 Increase, Closing at 1.41 - DWinneX
26,884 Shares in Cerus Co. (NASDAQ:CERS) Purchased by Pallas Capital Advisors LLC - Defense World
Cerus Corporation Celebrates World Blood Donor Day 2025 - Yahoo Finance
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership - Investing.com
Cerus at Goldman Sachs Conference: Pathogen Reduction Leadership By Investing.com - Investing.com Canada
Cerus Corp shareholders approve equity plan amendment By Investing.com - Investing.com South Africa
Cerus Corp shareholders approve equity plan amendment - Investing.com
Sigyn Therapeutics (OTCMKTS:SIGY) & Cerus (NASDAQ:CERS) Head to Head Comparison - Defense World
Two Sigma Investments LP Acquires 326,605 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Mackenzie Financial Corp Acquires 17,704 Shares of Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) - Defense World
3 Promising Penny Stocks With Market Caps Over $90M - Yahoo Finance
Cerus Management Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Coming June 11 - Stock Titan
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Cerus stock rating due to regulatory approvals - Investing.com
Cerus to present new INTERCEPT Blood System data at ISBT Congress - Investing.com
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Yahoo Finance
Breakthrough Phase 3 Results: New Clinical Data Shows INTERCEPT Blood System Success in Multiple Applications - Stock Titan
Cerus (CERS) Gains French and Swiss Regulatory Approvals for New Device | CERS Stock News - GuruFocus
Cerus gains regulatory nods for blood safety device in Europe - Investing.com
Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device - Business Wire
Cerus Co. (NASDAQ:CERS) Stake Boosted by Jane Street Group LLC - Defense World
When Should You Buy Cerus Corporation (NASDAQ:CERS)? - Yahoo Finance
Price T Rowe Associates Inc. MD Buys 34,694 Shares of Cerus Co. (NASDAQ:CERS) - Defense World
Stifel Financial Corp Grows Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Raymond James Financial Inc. Acquires Shares of 244,073 Cerus Co. (NASDAQ:CERS) - Defense World
Closing Strong: Cerus Corp (CERS) Ends at 1.25, Down -3.85 from Last Close - DWinneX
Cerus Corporation Announces First Quarter 2025 Financial Results - ADVFN
Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail
JPMorgan Chase & Co. Grows Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corporation (NASDAQ:CERS) Just Reported, And Analysts Assigned A US$4.25 Price Target - Yahoo Finance
Cerus Corporation (NASDAQ:CERS) Q1 2025 Earnings Call Transcript - Insider Monkey
Cerus Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Cerus: Q1 Earnings Snapshot - MySA
Earnings call transcript: Cerus Q1 2025 revenue up, stock dips post-earnings - Investing.com
CERUS CORP SEC 10-Q Report - TradingView
Cerus Corp Reports Q1 2025 Earnings: EPS Matches Estimate at -$0 - GuruFocus
Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Cerus Corp (CERS) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Cerus Corp (CERS) deserves deeper analysis - uspostnews.com
Trading Day Review: Cerus Corp (CERS) Loses Momentum, Closing at 1.34 - DWinneX
Geode Capital Management LLC Grows Stock Position in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corp (NASDAQ:CERS) Price Forecast For The Next 12 Months Is Set At 5. - Marketing Sentinel
Cerus Corp (CERS) deserves closer scrutiny - uspostnews.com
Vanguard Group Inc. Has $16.04 Million Stock Holdings in Cerus Co. (NASDAQ:CERS) - Defense World
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 - Yahoo Finance
Lobbying Update: $40,000 of CERUS CORPORATION lobbying was just disclosed - Nasdaq
After losing 21% in the past year, Cerus Corporation (NASDAQ:CERS) institutional owners must be relieved by the recent gain - simplywall.st
Raymond James Financial Inc. Purchases Shares of 244,073 Cerus Co. (NASDAQ:CERS) - Defense World
Cerus stock touches 52-week low at $1.19 amid market challenges - Investing.com
Virtu Financial LLC Takes $33,000 Position in Cerus Co. (NASDAQ:CERS) - Defense World
How Are Things Looking For Cerus Corp (NASDAQ: CERS) For The Short Term? - stocksregister.com
Cerus Corp Azioni (CERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cerus Corp Azioni (CERS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
| Jensen Chrystal | Chief Legal Officer |
Mar 07 '25 |
Sale |
1.50 |
27,457 |
41,131 |
832,318 |
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):